Bill > HB4643

This bill establishes new regulations for "liability shield products," which are defined as medical, pharmaceutical, biological, or technological products that have been granted immunity from liability under federal law. Manufacturers of these products must conduct placebo-controlled studies, which involve comparing the product's effects to a placebo (an inactive substance used as a control in studies), for at least five years and continuously collect data on safety outcomes like allergenicity (ability to cause allergic reactions), carcinogenicity (ability to cause cancer), fertility impact, immunogenicity (ability to cause an immune response), mutagenicity (ability to cause genetic mutations), and reactogenicity (symptoms or outcomes from a vaccine). The results of these studies and safety data must be made publicly available on the Department of Health's website. The Department of Health will also track and publish adverse outcomes reported through the West Virginia Health Information Network and the Vaccine Adverse Event Reporting System (VAERS), and issue alerts about any identified adverse consequences. Manufacturers have deadlines to submit documentation of initiated studies and final compliance reports detailing study results. The bill also explicitly states that individuals have the right to refuse a liability shield product without coercion, and outlines provisions for legal action by the Attorney General or individuals who suffer harm due to violations of these regulations, including potential civil penalties and damages.

Justice

http://www.wvlegislature.gov/Bill_Status/Bills_history.cfm?input=4643&year=2026&sessiontype=RS&btype=bill